loading

Tonix Pharmaceuticals Holding Corp 주식(TNXP)의 최신 뉴스

pulisher
Apr 25, 2025

Tonix Pharmaceuticals Holding CorpDiscontinued Enrollment And Terminated Phase 2 Catalyst StudySEC Filing - marketscreener.com

Apr 25, 2025
pulisher
Apr 25, 2025

Tonix Pharmaceuticals Reveals Promising Single-Dose Mpox Vaccine Data - citybuzz -

Apr 25, 2025
pulisher
Apr 24, 2025

Tonix reports promising results for mpox vaccine TNX-801 By Investing.com - Investing.com South Africa

Apr 24, 2025
pulisher
Apr 24, 2025

Tonix reports promising results for mpox vaccine TNX-801 - Investing.com

Apr 24, 2025
pulisher
Apr 24, 2025

Tonix Pharmaceuticals (TNXP) Unveils Promising Results for Single-Dose Mpox Vaccine | TNXP Stock News - GuruFocus

Apr 24, 2025
pulisher
Apr 24, 2025

Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress Washington 2025 | TNXP Stock News - GuruFocus

Apr 24, 2025
pulisher
Apr 24, 2025

Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress Washington 2025 - The Manila Times

Apr 24, 2025
pulisher
Apr 24, 2025

Tonix Pharmaceuticals Presented Data on Potential Mpox - GlobeNewswire

Apr 24, 2025
pulisher
Apr 24, 2025

Single-Dose Mpox Vaccine Breakthrough: Complete Protection for Immunocompromised Patients in Latest Trial - Stock Titan

Apr 24, 2025
pulisher
Apr 24, 2025

Tonix Pharma Presents Promising Vaccine Data at Congress - TipRanks

Apr 24, 2025
pulisher
Apr 23, 2025

Tonix Pharmaceuticals (TNXP) Falls Despite Market Upturn - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

Tonix Pharmaceuticals (TNXP) to Present at World Vaccine Congress - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

When the Price of (TNXP) Talks, People Listen - news.stocktradersdaily.com

Apr 23, 2025
pulisher
Apr 16, 2025

Tonix Pharmaceuticals Announces Oral Presentation And Panel Participation At The World Vaccine Congress Washington 2025 - marketscreener.com

Apr 16, 2025
pulisher
Apr 16, 2025

Tonix Pharmaceuticals Announces Oral Presentation and Panel - GlobeNewswire

Apr 16, 2025
pulisher
Apr 16, 2025

Major Breakthrough: Tonix Unveils Single-Dose Mpox Vaccine Data at Leading Global Conference - Stock Titan

Apr 16, 2025
pulisher
Apr 12, 2025

Why Tonix Pharmaceuticals Corp. (TNXP) Went Down On Thursday? - MSN

Apr 12, 2025
pulisher
Apr 09, 2025

Tonix and Makana partner on xenotransplantation research By Investing.com - Investing.com India

Apr 09, 2025
pulisher
Apr 09, 2025

Tonix Pharmaceuticals and Makana Therapeutics Announce Collabora - GuruFocus

Apr 09, 2025
pulisher
Apr 09, 2025

Tonix and Makana partner on xenotransplantation research - Investing.com

Apr 09, 2025
pulisher
Apr 09, 2025

Tonix Pharmaceuticals and Makana Therapeutics Announce - GlobeNewswire

Apr 09, 2025
pulisher
Apr 09, 2025

Tonix Pharmaceuticals And Makana Therapeutics Announce Collaboration Combining Tonix'S Anti-Cd40l Monoclonal Antibody (Tnx-1500) With Makana'S Genetically Engineered Organs In Preclinical And Clinical Xenotransplantation Studies - marketscreener.com

Apr 09, 2025
pulisher
Apr 09, 2025

Revolutionary Xenotransplantation Breakthrough: Tonix and Makana Join Forces to Combat Organ Failure - Stock Titan

Apr 09, 2025
pulisher
Apr 08, 2025

Tonix Pharmaceuticals launches :TONIX ONE™ A digital breakthrough in migraine management - Proactive financial news

Apr 08, 2025
pulisher
Apr 07, 2025

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting - GlobeNewswire

Apr 07, 2025
pulisher
Apr 07, 2025

Game-Changing Fibromyalgia Treatment Achieves Phase 3 Success, FDA Decision Looms - Stock Titan

Apr 07, 2025
pulisher
Apr 07, 2025

(TNXP) Investment Analysis - news.stocktradersdaily.com

Apr 07, 2025
pulisher
Apr 04, 2025

Peering Into Tonix Pharmaceuticals's Recent Short Interest - Benzinga

Apr 04, 2025
pulisher
Apr 03, 2025

TNXP: No AdCom Required for TNX-102 SL NDA… - Yahoo Finance

Apr 03, 2025
pulisher
Apr 02, 2025

Tonix Pharmaceuticals to Present at the 2025 Jones Trading Healthcare and Innovation Conference - GlobeNewswire

Apr 02, 2025
pulisher
Apr 02, 2025

Tonix Pharmaceuticals Reveals 5 Major Catalysts: FDA Decision, DoD Contract, and Breakthrough Therapies - Stock Titan

Apr 02, 2025
pulisher
Apr 01, 2025

Tonix Pharmaceuticals launches migraine management platform By Investing.com - Investing.com South Africa

Apr 01, 2025
pulisher
Apr 01, 2025

Tonix Pharmaceuticals Launches TONIX ONE™, a - GlobeNewswire

Apr 01, 2025
pulisher
Apr 01, 2025

Tonix Pharma stock rises following TONIX ONE launch By Investing.com - Investing.com South Africa

Apr 01, 2025
pulisher
Apr 01, 2025

Tonix Pharma stock rises following TONIX ONE launch - Investing.com Australia

Apr 01, 2025
pulisher
Apr 01, 2025

Tonix Pharmaceuticals launches migraine management platform - Investing.com

Apr 01, 2025
pulisher
Apr 01, 2025

Tonix Pharmaceuticals Launches TONIX ONE™, a Fully-Integrated Digital Platform Designed to Help Patients Better Understand and Manage Their Migraine Condition - GlobeNewswire

Apr 01, 2025
pulisher
Apr 01, 2025

Game-Changing Digital Platform Transforms How Patients Track and Treat Migraines - Stock Titan

Apr 01, 2025
pulisher
Mar 31, 2025

Tonix’s Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Lat - PharmiWeb.com

Mar 31, 2025
pulisher
Mar 31, 2025

Tonix’s Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year - ACCESS Newswire

Mar 31, 2025
pulisher
Mar 31, 2025

Revolutionary Non-Opioid Pain Drug Could Transform Fibromyalgia Treatment by 2025 - Stock Titan

Mar 31, 2025
pulisher
Mar 29, 2025

New to The Street Show #639 Premieres Nationwide on Bloomberg Television, March 29 at 6:30 PM EST Featuring BioVie, Roadzen, Tonix Pharma, and eXoZymes Inc. - Bluefield Daily Telegraph

Mar 29, 2025
pulisher
Mar 27, 2025

(TNXP) Long Term Investment Analysis - Stock Traders Daily

Mar 27, 2025
pulisher
Mar 27, 2025

Tonix Pharmaceuticals Announces Presentation at the - GlobeNewswire

Mar 27, 2025
pulisher
Mar 27, 2025

Fast-Tracked Fibromyalgia Treatment: Tonix Showcases Breakthrough Pain Drug Data Before FDA Decision - StockTitan

Mar 27, 2025
pulisher
Mar 26, 2025

2 Stocks Riding the Biotech Surge With Major Catalysts Ahead - Investing.com

Mar 26, 2025
pulisher
Mar 26, 2025

Tonix Pharmaceuticals: Potential To Have 'First' New Fibromyalgia Drug In 15 Years - Seeking Alpha

Mar 26, 2025
pulisher
Mar 25, 2025

Noble Capital maintains Outperform on Tonix Pharma, $70 target By Investing.com - Investing.com South Africa

Mar 25, 2025
pulisher
Mar 25, 2025

Noble Capital maintains Outperform on Tonix Pharma, $70 target - Investing.com

Mar 25, 2025
pulisher
Mar 25, 2025

Tonix Pharmaceuticals: FDA AdCom News Positive, But Making Bull Case Is Problematic (TNXP) - Seeking Alpha

Mar 25, 2025
pulisher
Mar 25, 2025

Pharma Frenzy: Volatility Ignites Biotech Sector - Benzinga

Mar 25, 2025
pulisher
Mar 25, 2025

Top 2 Health Care Stocks That Are Ticking Portfolio Bombs - Benzinga

Mar 25, 2025
pulisher
Mar 24, 2025

Tonix advances fibromyalgia drug, eyes Q4 2025 launch By Investing.com - Investing.com Australia

Mar 24, 2025
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
자본화:     |  볼륨(24시간):